Ra Capital Management as of Dec. 31, 2019
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 34 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Synthorx | 20.6 | $680M | 9.7M | 69.89 | |
| Ascendis Pharma A S (ASND) | 17.7 | $582M | 4.2M | 139.12 | |
| Ra Pharmaceuticals | 6.9 | $228M | 4.9M | 46.93 | |
| Arvinas Ord (ARVN) | 4.6 | $151M | 3.7M | 41.09 | |
| Chemocentryx | 3.8 | $127M | 3.2M | 39.55 | |
| Rhythm Pharmaceuticals (RYTM) | 3.8 | $125M | 5.4M | 22.96 | |
| Eidos Therapeutics | 3.8 | $124M | 2.2M | 57.39 | |
| Zogenix | 3.6 | $118M | 2.3M | 52.13 | |
| Phathom Pharmaceuticals (PHAT) | 3.4 | $114M | 3.6M | 31.14 | |
| Tg Therapeutics (TGTX) | 3.3 | $110M | 9.9M | 11.10 | |
| Satsuma Pharmaceuticals Ord | 2.8 | $92M | 4.7M | 19.68 | |
| Orchard Therapeutics Plc ads | 2.7 | $88M | 6.4M | 13.75 | |
| 89bio (ETNB) | 2.5 | $83M | 3.2M | 26.29 | |
| Forty Seven | 2.3 | $76M | 1.9M | 39.37 | |
| Wave Life Sciences (WVE) | 1.9 | $62M | 7.8M | 8.01 | |
| Retrophin | 1.8 | $60M | 4.3M | 14.20 | |
| Audentes Therapeutics | 1.6 | $54M | 902k | 59.84 | |
| Prevail Therapeutics Ord | 1.6 | $53M | 3.4M | 15.83 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.4 | $47M | 1.9M | 25.09 | |
| Ardelyx (ARDX) | 1.2 | $40M | 5.4M | 7.50 | |
| Axsome Therapeutics (AXSM) | 1.1 | $38M | 368k | 103.36 | |
| Igm Biosciences (IGMS) | 1.1 | $38M | 983k | 38.16 | |
| Stoke Therapeutics (STOK) | 1.0 | $32M | 1.1M | 28.32 | |
| Relmada Therapeutics (RLMD) | 0.9 | $30M | 762k | 39.00 | |
| Momenta Pharmaceuticals | 0.9 | $29M | 1.4M | 19.73 | |
| Solid Biosciences | 0.6 | $20M | 4.6M | 4.45 | |
| Scpharmaceuticals (SCPH) | 0.6 | $18M | 3.2M | 5.66 | |
| Alector (ALEC) | 0.5 | $17M | 1.0M | 17.23 | |
| Kala Pharmaceuticals | 0.5 | $17M | 4.5M | 3.69 | |
| Galera Therapeutics (GRTX) | 0.4 | $14M | 1.1M | 13.16 | |
| Dynavax Technologies (DVAX) | 0.4 | $14M | 2.4M | 5.72 | |
| Portola Pharmaceuticals | 0.3 | $10M | 429k | 23.88 | |
| Essa Pharma (EPIX) | 0.2 | $5.5M | 1.0M | 5.50 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $2.9M | 270k | 10.70 |
